Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue EUCOR Newsletter Année : 2020

Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study

Fichier non déposé

Dates et versions

hal-03572222 , version 1 (14-02-2022)

Identifiants

  • HAL Id : hal-03572222 , version 1

Citer

Jean-Sylvain Hermida, Stewart Healey, Giuseppe Arena, Nicolas Badenco, Christian Meyer, et al.. Cryoballoon Catheter Ablation versus Antiarrhythmic Drug as a First-Line Therapy for Patients With Paroxysmal Atrial Fibrillation: Results of the Cryo-FIRST Study. EUCOR Newsletter, 2020, 142 (3). ⟨hal-03572222⟩
37 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More